Figure 2
From: Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio
Effects of cisplatin on cell viability of HepG2 cancer cells and non-malignant Vero and Chang liver cell lines. The effectiveness of cisplatin on HepG2 cells and non-malignant Chang Liver cells did not significantly differ since the IC50 obtained for both malignant and non-malignant were 7 μg/ml. The IC50 of cisplatin-treated non-malignant Vero cells was 9.06 ± 0.044 μg/ml.